Assignee
S-TARGET THERAPEUTICS GMBH
AT·3 granted patents·2 pending applications·4 citations·filing 2013–2017
Top patents by PatentIndex Score
5 records- 0179US9636415B2Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergiesS-TARGET THERAPEUTICS GMBH·Filed 2013·Granted May 2, 2017·2 cites·15 claims
- 0278US10189905B2Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergiesS TARGET THERAPEUTICS GMBH·Filed 2017·Granted Jan 29, 2019·1 cites·12 claims
- 0366US10434170B2Immunoregulatory vaccineS TARGET THERAPEUTICS GMBH·Filed 2013·Granted Oct 8, 2019·1 cites·13 claims
- 0443US2017334992A9Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergiesS-TARGET THERAPEUTICS GMBH·Filed 2016·Application pending·0 cites
- 0540US2017320942A1Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergiesS-TARGET THERAPEUTICS GMBH·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →